SANTANDREA, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.710
NA - Nord America 1.594
EU - Europa 866
SA - Sud America 225
AF - Africa 83
Continente sconosciuto - Info sul continente non disponibili 34
OC - Oceania 11
Totale 4.523
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.522
CN - Cina 508
SG - Singapore 425
IT - Italia 353
HK - Hong Kong 188
BR - Brasile 171
VN - Vietnam 171
GB - Regno Unito 109
BD - Bangladesh 84
KR - Corea 82
DE - Germania 75
RU - Federazione Russa 63
SE - Svezia 56
IN - India 50
FR - Francia 42
ID - Indonesia 39
CA - Canada 34
EG - Egitto 34
FI - Finlandia 32
NL - Olanda 28
MX - Messico 27
AR - Argentina 25
PK - Pakistan 25
IQ - Iraq 24
IR - Iran 23
ZA - Sudafrica 19
PL - Polonia 17
TR - Turchia 14
LT - Lituania 13
UA - Ucraina 12
AU - Australia 11
JP - Giappone 11
PH - Filippine 11
CO - Colombia 10
EC - Ecuador 10
ES - Italia 10
IL - Israele 9
AE - Emirati Arabi Uniti 7
AT - Austria 7
BE - Belgio 7
CH - Svizzera 7
NG - Nigeria 7
SA - Arabia Saudita 7
IE - Irlanda 6
MA - Marocco 6
MY - Malesia 6
JO - Giordania 5
PT - Portogallo 5
BG - Bulgaria 4
DZ - Algeria 4
PY - Paraguay 4
RO - Romania 4
RS - Serbia 4
UZ - Uzbekistan 4
AM - Armenia 3
ET - Etiopia 3
JM - Giamaica 3
PA - Panama 3
SN - Senegal 3
BF - Burkina Faso 2
GR - Grecia 2
HR - Croazia 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HN - Honduras 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
OM - Oman 1
QA - Qatar 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 4.489
Salva come PNG Salva come JPEG
Città #
Santa Clara 285
Ashburn 266
Singapore 262
Hefei 227
Hong Kong 176
San Jose 123
Council Bluffs 69
Seoul 69
Ho Chi Minh City 60
Beijing 59
London 56
New York 53
Los Angeles 51
Milan 38
Chandler 35
Hanoi 29
Rome 29
Chicago 27
Buffalo 26
The Dalles 26
Helsinki 25
Cairo 23
Jakarta 23
Shanghai 23
São Paulo 23
Fairfield 21
Bologna 20
Lauterbourg 20
Nyköping 20
Kent 16
Munich 16
Schiffdorf 16
Moscow 15
Orem 15
Warsaw 15
Dallas 14
Johannesburg 14
Naples 11
Salt Lake City 11
Amsterdam 10
Da Nang 10
Florence 10
Mexico City 10
Modena 10
Bari 9
Islamabad 9
Nuremberg 9
Tokyo 9
Brembate di Sopra 8
Denver 8
Houston 8
Montreal 8
Rio de Janeiro 8
Toronto 8
Turin 8
Wuhan 8
Atlanta 7
Baghdad 7
Cambridge 7
Catania 7
Guayaquil 7
Haiphong 7
Istanbul 7
Phoenix 7
Boston 6
Dhaka 6
Dublin 6
Giza 6
Poplar 6
Portsmouth 6
Raleigh 6
Redondo Beach 6
Seattle 6
Amman 5
Ann Arbor 5
Antwerp 5
Bagno a Ripoli 5
Belo Horizonte 5
Bengaluru 5
Brooklyn 5
Campi Bisenzio 5
Charlotte 5
Kunming 5
Lagos 5
Lahore 5
Las Vegas 5
Manchester 5
Miami 5
Migliarino 5
Parma 5
San Diego 5
Turku 5
Austin 4
Belgrade 4
Boardman 4
Bremen 4
Chennai 4
Düsseldorf 4
Erbil 4
Geneva 4
Totale 2.694
Salva come PNG Salva come JPEG
Nome #
Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists 575
Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer 242
Clinical Review of Mucosal Melanoma: The 11-Year Experience of a Referral Center 239
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 1: Focus on immunohistochemical results with discussion of pre-analytical and interpretation variables 233
How can we treat vulvar carcinoma in pregnancy? A systematic review of the literature 216
Sinonasal NUT Carcinoma: Delayed Diagnosis Due to the COVID-19 Pandemic and a Review of the Literature 205
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 199
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. part 4: Experimental treatments in pre-clinical studies (cell lines and mouse models) 194
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 5: Epigenetic regulation of pd-l1 177
Biomarkers changes after neoadjuvant chemotherapy in breast cancer: A seven-year single institution experience 173
Patient derived organoids are an useful tool to investigate Hippo pathway involvement in lung cancer 169
PRAME expression in cellular neurothekeoma: A study of 11 cases 163
Clinically unquestionable but histologically deceptive melanomas in acral skin grafts: PRAME confirms its role 160
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling 156
What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review. Part 3: PD-L1, intracellular signaling pathways and tumor microenvironment 154
What do we have to know about pd-l1 expression in prostate cancer? A systematic literature review. part 2: Clinic–pathologic correlations 147
Implementing an organoid platform to assess efficacy of PHD inhibitors as anti-cancer agents 143
PHD2 (EGLN1) is a novel therapeutic target in KRAS-mutated lung carcinoma 138
Digital spatial profiling for pathologists 137
LncRNA TAZ-AS202 promotes lung cancer progression through the regulation of the E2F1 transcription factor 128
Medullary Thyroid Carcinomas Classified According to the International Medullary Carcinoma Grading System and a Surveillance, Epidemiology, and End Results-Based Metastatic Risk Score: A Correlation With Genetic Profile and Angioinvasion 125
A Two-Step Protocol for Isolation and Maintenance of Lung Cancer Primary 3D Cultures 110
Harnessing the hypoxia pathway to set a new therapeutic strategy for KRAS-mutated lung adenocarcinoma 103
Characterization of EGLN1 as a pro-oncogenic factor and pharmacological target in lung cancer 91
null 83
Exploring EGLN1 as a therapeutic target for KRAS mutated lung cancer 63
Totale 4.523
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202256 0 18 0 0 2 6 3 8 2 2 8 7
2022/2023129 9 12 6 5 10 14 2 15 12 13 14 17
2023/2024442 17 17 30 40 53 40 61 42 18 48 38 38
2024/20251.233 18 41 45 100 215 175 115 65 147 53 118 141
2025/20262.517 221 157 221 295 332 94 291 113 271 215 209 98
2026/2027125 97 28 0 0 0 0 0 0 0 0 0 0
Totale 4.523